Short answer
Pacira BioSciences, Inc. (PCRX) filed an 8-K current report with the SEC on February 26, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q4 and full-year 2025 earnings announced Feb 26, 2026; period ended Dec 31, 2025.
Pacira BioSciences, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q4 and full-year 2025 earnings announced Feb 26, 2026; period ended Dec 31, 2025
- Full financial results contained in Exhibit 99.1: key figures require review of attached press release
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Pacira BioSciences, Inc. 8-K filings
Get the next PCRX 8-K as it lands
Follow PCRX for push alerts, or ask the research agent what this filing means.